Literature DB >> 17062439

Systemic sclerosis and bone loss: the role of the disease and body composition.

R B C Souza1, C T L Borges, L Takayama, J M Aldrighi, R M R Pereira.   

Abstract

OBJECTIVES: Studies on body composition are not available in systemic sclerosis (SSc). As this variable may play an important role in bone loss we have analysed bone mineral density (BMD) and body composition in SSc patients and healthy controls.
METHODS: Forty-three postmenopausal SSc patients and 47 healthy postmenopausal women were studied. Patients with intestinal malabsorption, renal failure, current or past history of smoking or using osteopenic drugs were excluded. BMD and body composition was evaluated by dual X-ray absorptiometry (DXA).
RESULTS: A higher frequency of osteoporosis in the lumbar spine (32.5%) and femoral neck (51.1%) was observed in SSc patients when compared to controls (14.8% vs. 19.1%; p<0.01). Multiple linear regression analysis revealed an association between the presence of SSc and low BMD. Body composition showed a reduced lean mass (33.15 vs. 39.99 g; p<0.01) and fat mass (21.05 vs. 26.82 g; p<0.01) in SSc when compared to controls. Lean mass was an important factor related to BMD in the lumbar spine and femoral neck.
CONCLUSION: SSc may be an independent factor for low BMD. The low lean mass in these patients emphasizes the need for appropriate additional therapeutic measures to reduce bone loss in SSc patients.

Entities:  

Mesh:

Year:  2006        PMID: 17062439     DOI: 10.1080/03009740600704296

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  23 in total

1.  Low bone mass in juvenile onset sclerosis systemic: the possible role for 25-hydroxyvitamin D insufficiency.

Authors:  Samuel Katsuyuki Shinjo; Eloisa Bonfá; Valéria de Falco Caparbo; Rosa Maria Rodrigues Pereira
Journal:  Rheumatol Int       Date:  2010-03-25       Impact factor: 2.631

2.  Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis.

Authors:  Chider Chen; Dandan Wang; Alireza Moshaverinia; Dawei Liu; Xiaoxing Kou; Wenjing Yu; Ruili Yang; Lingyun Sun; Songtao Shi
Journal:  Cell Res       Date:  2017-01-20       Impact factor: 25.617

3.  Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Fahd Wafki; Fatima Znat; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2011-09-27       Impact factor: 2.631

4.  Vertebral fracture prevalence and measurement of the scanographic bone attenuation coefficient on CT-scan in patients with systemic sclerosis.

Authors:  Marine Fauny; Elodie Bauer; Eliane Albuisson; Julia Perrier-Cornet; Joëlle Deibener; François Chabot; Damien Mandry; Olivier Huttin; Isabelle Chary-Valckenaere; Damien Loeuille
Journal:  Rheumatol Int       Date:  2018-08-21       Impact factor: 2.631

5.  Relationship between body composition and both cardiovascular risk factors and lung function in systemic sclerosis.

Authors:  Paola Caramaschi; Domenico Biasi; Cristian Caimmi; Giovanni Barausse; Davide Gatti; Marcello Ferrari; Sara Pieropan; Dania Sabbagh; Silvano Adami
Journal:  Clin Rheumatol       Date:  2013-09-20       Impact factor: 2.980

6.  Distal radius and tibia bone microarchitecture impairment in female patients with diffuse systemic sclerosis.

Authors:  M M Sampaio-Barros; J C Alvarenga; L Takayama; A P L Assad; P D Sampaio-Barros; R M R Pereira
Journal:  Osteoporos Int       Date:  2019-04-27       Impact factor: 4.507

7.  Glucocorticoid-related changes in body mass index among children and adolescents with rheumatic diseases.

Authors:  Natalie J Shiff; Rollin Brant; Jaime Guzman; David A Cabral; Adam M Huber; Paivimm Miettunen; Johannes Roth; Rosie Scuccimarri; Nathalie Alos; Stephanie A Atkinson; Jean Paul Collet; Robert Couch; Elizabeth A Cummings; Peter B Dent; Janet Ellsworth; John Hay; Kristin Houghton; Roman Jurencak; Bianca Lang; Maggie Larche; Claire Leblanc; Celia Rodd; Claire Saint-Cyr; Robert Stein; David Stephure; Shayne Taback; Frank Rauch; Leanne M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-01       Impact factor: 4.794

8.  Risk factors for body composition abnormalities in systemic sclerosis.

Authors:  Thais F Marighela; Patrícia de S Genaro; Marcelo M Pinheiro; Vera L Szejnfeld; Cristiane Kayser
Journal:  Clin Rheumatol       Date:  2013-04-03       Impact factor: 2.980

Review 9.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

Review 10.  Glucocorticoid-induced osteoporosis in rheumatic diseases.

Authors:  Rosa Maria Rodrigues Pereira; Jozélio Freire de Carvalho; Ernesto Canalis
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.